Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes
出版年份 2016 全文链接
标题
Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes
作者
关键词
Clinical trial data, Diabetes mellitus, Hypoglycemia, Hypoglycemia event rates, Insulin, Nocturnal hypoglycemia, Real world data, Severe hypoglycemia
出版物
Diabetes Therapy
Volume 7, Issue 1, Pages 45-60
出版商
Springer Nature
发表日期
2016-02-17
DOI
10.1007/s13300-016-0157-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool
- (2015) W. A. Parekh et al. DIABETIC MEDICINE
- Hypoglycemia in Older People - A Less Well Recognized Risk Factor for Frailty
- (2015) Ahmed H Abdelhafiz et al. Aging and Disease
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)
- (2014) John B. Buse et al. DIABETES CARE
- The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes
- (2013) L. Meneghini et al. DIABETES CARE
- Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes
- (2013) Stephen C.L. Gough et al. DIABETES CARE
- Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
- (2013) E. R. Seaquist et al. DIABETES CARE
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes
- (2013) L. Meneghini et al. DIABETES OBESITY & METABOLISM
- Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents
- (2013) A. Philis-Tsimikas et al. DIABETES OBESITY & METABOLISM
- Treat-to-target trials: uses, interpretation and review of concepts
- (2013) A. J. Garber DIABETES OBESITY & METABOLISM
- Self-reported non-severe hypoglycaemic events in Europe
- (2013) C. G. Östenson et al. DIABETIC MEDICINE
- Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial
- (2013) H. W. Rodbard et al. DIABETIC MEDICINE
- Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN®Basal-Bolus Type 1): 2-year results of a randomized clinical trial
- (2013) B. W. Bode et al. DIABETIC MEDICINE
- Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
- (2013) Chantal Mathieu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Insulin degludec compared with insulin glargine in insulin-naïve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial
- (2013) Yukiko Onishi et al. Journal of Diabetes Investigation
- Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries
- (2013) Petronella H. Geelhoed-Duijvestijn et al. JOURNAL OF MEDICAL ECONOMICS
- Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians
- (2012) Meryl Brod et al. CURRENT MEDICAL RESEARCH AND OPINION
- Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets
- (2012) J. H. DeVries et al. DIABETES CARE
- Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, phase 3, randomized, open-label, treat-to-target trial
- (2012) I. B. Hirsch et al. DIABETES CARE
- Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)
- (2012) B. Zinman et al. DIABETES CARE
- The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries
- (2012) K. Khunti et al. DIABETES OBESITY & METABOLISM
- A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study
- (2012) K. Bowering et al. DIABETIC MEDICINE
- Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs
- (2012) N. Hex et al. DIABETIC MEDICINE
- Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings
- (2012) V. Pīrāgs et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Alan J Garber et al. LANCET
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
- (2012) Simon Heller et al. LANCET
- Uncovering undetected hypoglycemic events
- (2012) Jeffrey Unger Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Impaired awareness of hypoglycaemia: a review
- (2011) A.J. Graveling et al. DIABETES & METABOLISM
- The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial: Comparing the durability of lispro mix 75/25 and glargine
- (2011) J. B. Buse et al. DIABETES CARE
- An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study
- (2011) Philip Home et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Starting or switching to biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes: A multicenter, observational, primary care study conducted in Finland
- (2011) Jyrki K. Mäkelä et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Insulin analogues and severe hypoglycaemia in type 1 diabetes
- (2011) P.L. Kristensen et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Strategies for insulin initiation: insights from the French LIGHT observational study
- (2011) Bruno Vergès et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management
- (2011) Meryl Brod et al. VALUE IN HEALTH
- First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
- (2011) Shih-Tzer TSAI et al. Journal of Diabetes
- Initiation of biphasic insulin aspart 30/70 in subjects with type 2 diabetes mellitus in a largely primary care-based setting in Sweden
- (2011) Kerstin Berntorp et al. Primary Care Diabetes
- Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: A noninferiority intensification substudy of the DURABLE trial
- (2010) William F. Miser et al. CLINICAL THERAPEUTICS
- Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetes
- (2010) S. M. Jain et al. DIABETES OBESITY & METABOLISM
- Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial
- (2010) Julio Rosenstock et al. LANCET
- Frequency of Hypoglycemia and Its Significance in Chronic Kidney Disease
- (2009) M. F. Moen et al. Clinical Journal of the American Society of Nephrology
- Hypoglycaemia: An overview
- (2009) Alex J. Graveling et al. Primary Care Diabetes
- Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial
- (2008) A. Liebl et al. DIABETES OBESITY & METABOLISM
- Hypoglycaemia in Type 2 diabetes
- (2008) S. A. Amiel et al. DIABETIC MEDICINE
- Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia
- (2008) S. G. H. A. Swinnen et al. DIABETOLOGIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started